3D4 Pedia: A “Printed” Drug Tailored to Patients’ Needs
The collaboration between laboratories atthe University of Montpellier (UM) and MB Therapeutics is paving the way for a new generation of personalized treatments: thanks to 3D printing technology that has been in development for several years, the 3D4 Pedia project could revolutionize drug therapy for young patients.
A major breakthrough in pediatric medicine, driven by innovation from Montpellier and the expertise of a pioneering industry player, with support from the Companies and Campus program.
Read the full article: 3D4 Pedia – a 3D-printed medication tailored to patients’ needs
co-founder of MB Therapeutics, and head of the drug production unit at the Nîmes University Hospital